8-90645694-T-C
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001008495.4(TMEM64):āc.212A>Gā(p.Glu71Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000207 in 1,448,912 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001008495.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00000666 AC: 1AN: 150116Hom.: 0 Cov.: 32
GnomAD4 exome AF: 0.00000154 AC: 2AN: 1298796Hom.: 0 Cov.: 31 AF XY: 0.00000157 AC XY: 1AN XY: 637440
GnomAD4 genome AF: 0.00000666 AC: 1AN: 150116Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 73230
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 26, 2024 | The c.212A>G (p.E71G) alteration is located in exon 1 (coding exon 1) of the TMEM64 gene. This alteration results from a A to G substitution at nucleotide position 212, causing the glutamic acid (E) at amino acid position 71 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at